Estrogen receptor–β activated apoptosis in benign hyperplasia and cancer of the prostate is androgen independent and TNFα mediated
Open Access
- 16 February 2010
- journal article
- research article
- Published by Proceedings of the National Academy of Sciences in Proceedings of the National Academy of Sciences
- Vol. 107 (7), 3123-3128
- https://doi.org/10.1073/pnas.0905524107
Abstract
Prostate cancer (PCa) and benign prostatic hyperplasia (BPH) are androgen-dependent diseases commonly treated by inhibiting androgen action. However, androgen ablation or castration fail to target androgen-independent cells implicated in disease etiology and recurrence. Mechanistically different to castration, this study shows beneficial proapoptotic actions of estrogen receptor–β (ERβ) in BPH and PCa. ERβ agonist induces apoptosis in prostatic stromal, luminal and castrate-resistant basal epithelial cells of estrogen-deficient aromatase knock-out mice. This occurs via extrinsic (caspase-8) pathways, without reducing serum hormones, and perturbs the regenerative capacity of the epithelium. TNFα knock-out mice fail to respond to ERβ agonist, demonstrating the requirement for TNFα signaling. In human tissues, ERβ agonist induces apoptosis in stroma and epithelium of xenografted BPH specimens, including in the CD133+ enriched putative stem/progenitor cells isolated from BPH-1 cells in vitro. In PCa, ERβ causes apoptosis in Gleason Grade 7 xenografted tissues and androgen-independent cells lines (PC3 and DU145) via caspase-8. These data provide evidence of the beneficial effects of ERβ agonist on epithelium and stroma of BPH, as well as androgen-independent tumor cells implicated in recurrent disease. Our data are indicative of the therapeutic potential of ERβ agonist for treatment of PCa and/or BPH with or without androgen withdrawal.Keywords
This publication has 40 references indexed in Scilit:
- The Role of CD133 in Normal Human Prostate Stem Cells and Malignant Cancer-Initiating CellsCancer Research, 2008
- Effects of estrogen receptor alpha- and beta-selective substances in the metaphysis of the tibia and on serum parameters of bone and fat tissue metabolism of ovariectomized ratsBone, 2008
- Estrogen-regulated development and differentiation of the prostateDifferentiation, 2008
- Estrogen-Dependent Signaling in a Molecularly Distinct Subclass of Aggressive Prostate CancerJNCI Journal of the National Cancer Institute, 2008
- Ligand-dependent activation of ER lowers blood pressure and attenuates cardiac hypertrophy in ovariectomized spontaneously hypertensive ratsCardiovascular Research, 2007
- Treating prostate cancer: a rationale for targeting local oestrogensNature Reviews Cancer, 2007
- Toremifene for the Prevention of Prostate Cancer in Men With High Grade Prostatic Intraepithelial Neoplasia: Results of a Double-Blind, Placebo Controlled, Phase IIB Clinical TrialJournal of Urology, 2006
- Prospective Identification of Tumorigenic Prostate Cancer Stem CellsCancer Research, 2005
- Distinct roles for lymphotoxin‐α and tumor necrosis factor in organogenesis and spatial organization of lymphoid tissueEuropean Journal of Immunology, 1997
- An edgewise look at basal epithelial cells: Three-dimensional views of the rat prostate, mammary gland and salivary glandDifferentiation, 1996